Anaptysbio ANAB
NASDAQ ANAB
$56.80 -0.66 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Anaptysbio (ANAB) Tax Provisions (2018 - 2026)

Anaptysbio's (ANAB) quarterly Tax Provisions came in at $40000.0 in Q1 2026, down 9.09% YoY from $44000.0 in Q1 2025, and up 107.52% on a QoQ basis from -$532000.0 in Q4 2025.

Analysis

Anaptysbio (ANAB) Tax Provisions (2018 - 2026) Analysis & Trends

Anaptysbio (ANAB) has 6 years of Tax Provisions data on file, last reported at $40000.0 in Q1 2026.

  • Quarterly Tax Provisions fell 9.09% year-over-year to $40000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$453000.0 (up 98.51% YoY) and the FY2025 annual result came in at -$449000.0, up 98.53% from the prior year.
  • Tax Provisions grew to $40000.0 in Q1 2026, from -$532000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $44000.0 in Q1 2025 to a low of -$30.5 million in Q4 2024.
  • A 4-year average of -$4.4 million and a median of $9000.0 in 2024 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2024 — Tax Provisions plunged 762575.0% — and 2025, when it jumped 333.33%.
  • Tracing ANAB's Tax Provisions over 4 years: stood at -$4000.0 in 2023, then sank by 762575.0% to -$30.5 million in 2024, then surged by 98.26% to -$532000.0 in 2025, then surged by 107.52% to $40000.0 in 2026.
  • The last three Tax Provisions figures came in at $40000.0 (Q1 2026), -$532000.0 (Q4 2025), and $39000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -59.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.90 Mn
10 Anaptysbio 1.62 Bn 1.34 Bn - 40,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 40,000.00
Dec 31, 2025 -2.83 Mn
Jun 30, 2025 39,000.00
Mar 31, 2025 44,000.00
Dec 31, 2024 -30.51 Mn
Jun 30, 2024 9,000.00
Dec 31, 2023 -34.36 Mn
Dec 31, 2019 -22,000.00
Sep 30, 2019 -51,000.00
Jun 30, 2019 -60,000.00
Mar 31, 2019 -19,000.00
Dec 31, 2018 -192,000.00